Winner of the 2017 SPIN Award Program


09.07.2017
  • Created in 2008, the SPIN Award Program supports the development and testing of innovative ideas and hypotheses in the field of immunoglobulin research in neurology
  • The SPIN 2017 was awarded to Ruth Huizinga, PhD from Erasmus Medical Center Rotterdam, to study the effect of IVIg on the B-cell receptor repertoire of patients with the Guillain-Barré syndrome
  • Dr. Huizinga received the SPIN Award during the Peripheral Nerve Society (PNS) Meeting at Sitges, Barcelona, Spain

 

Sitges (Barcelona), Spain, July 09, 2017 - For the ninth consecutive year, Grifols presented the SPIN (Scientific Progress – Immunoglobulins in Neurology) Award as a part of the Grifols Scientific Awards program, which is committed to promoting scientific research.

The SPIN Award Program supports the development and testing of innovative ideas and hypotheses in the field of immunoglobulin research in neurology. Formerly awarded only to European Investigators, the SPIN Award now invites applications from around the globe.

The winner of this year's SPIN Award is Dr. Ruth Huizinga from the Erasmus Medical Center in Rotterdam, Netherlands.

Her project, "Effect of IVIg on the B-cell receptor repertoire of patients with the Guillain-Barré syndrome" will investigate how intravenous immunoglobulins (IVIg) influence the B-cell receptor (BCR) repertoire in patients with Guillain-Barré syndrome (GBS) and if these changes affect the clinical outcome, potentially elucidating the mode of action of IVIG in the treatment of patients suffering from GBS.

About the SPIN Award Program

The SPIN program offers a prize of €50,000 for the proposal that best matches the program's objectives:

  • To develop novel concepts in immunoglobulin research in neurology
  • To encourage the discovery of beneficial immunoglobulin applications in neurological disorders
  • To promote research on novel therapeutic options for patients with neurological conditions.

The application process for the 2018 cycle commences on August 1, 2017 and will remain open until January 31, 2018.

Applicants are asked to submit a letter of intent outlining the goals of their research project. After this step, the independent Review Committee invites a shortlist of candidates to submit a full proposal. The full proposals are then evaluated, and a final selection is made.

The program is open to clinicians and researchers under 40 years of age. Profit-oriented projects and pharmaceutical companies are not considered.

More information regarding the SPIN award, qualifications and the application procedure can be found at: http://www.spin-awards.com/.